Corcept Therapeutics Incorporated
CORT
$57.08
$5.9211.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -64.67% | -29.43% | -25.18% | 6.09% | 13.53% |
| Total Depreciation and Amortization | 25.14% | 41.47% | 62.72% | 101.49% | -3.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 231.56% | 309.39% | 747.67% | 70.03% | 26.27% |
| Change in Net Operating Assets | -13.43% | -103.87% | 258.39% | 359.30% | 650.11% |
| Cash from Operations | -33.02% | -28.57% | 13.27% | 47.13% | 43.63% |
| Capital Expenditure | 86.47% | 90.29% | 86.25% | -323.18% | -1,537.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 145.89% | 139.88% | 118.62% | 75.49% | -35.11% |
| Cash from Investing | 145.10% | 139.28% | 117.93% | 74.37% | -36.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 150.89% | 165.08% | 152.22% | 163.79% | 86.87% |
| Repurchase of Common Stock | -163.78% | -547.59% | -576.48% | -1,282.64% | 49.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -165.95% | -677.33% | -741.54% | -2,781.96% | 54.76% |
| Foreign Exchange rate Adjustments | 788.46% | 889.47% | 102.64% | 32,266.67% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.57% | 9.08% | -147.67% | 40.98% | 60.10% |